149 related articles for article (PubMed ID: 24343098)
1. Bone metastasis in primary endometrial carcinoma: features, outcomes, and predictors.
Yoon A; Choi CH; Kim TH; Choi JK; Park JY; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2014 Jan; 24(1):107-12. PubMed ID: 24343098
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological features and prognosis of patients in endometrial cancer with bone metastases].
Jiang F; Ren T; Cheng NH; Cao DY; Yang JX; Wu M; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2019 Jul; 54(7):452-457. PubMed ID: 31365957
[No Abstract] [Full Text] [Related]
3. Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer.
Kehoe SM; Zivanovic O; Ferguson SE; Barakat RR; Soslow RA
Gynecol Oncol; 2010 May; 117(2):229-33. PubMed ID: 20199802
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Survival After Recurrence in Women With Early-Stage Endometrial Carcinoma.
Xu Y; Burmeister C; Hanna RK; Munkarah A; Elshaikh MA
Int J Gynecol Cancer; 2016 Jul; 26(6):1137-42. PubMed ID: 27206283
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes and patterns of failure in women with stage IIIC
Lee JK; Mahan M; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
[TBL] [Abstract][Full Text] [Related]
7. Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 Cases.
Abdulfatah E; Sakr S; Thomas S; Al-Wahab Z; Mutch DG; Dowdy S; Bandyopadhyay S; Munkarah A; Elshaikh M; Morris R; Ali-Fehmi R
Int J Gynecol Cancer; 2017 Oct; 27(8):1714-1721. PubMed ID: 28945214
[TBL] [Abstract][Full Text] [Related]
8. Is time to recurrence after hysterectomy predictive of survival in patients with early stage endometrial carcinoma?
Robbins JR; Yechieli R; Laser B; Mahan M; Rasool N; Elshaikh MA
Gynecol Oncol; 2012 Oct; 127(1):38-42. PubMed ID: 22796549
[TBL] [Abstract][Full Text] [Related]
9. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
10. Contributing factors for bone metastasis in uterine cervical cancer.
Yoon A; Choi CH; Kim HJ; Park JY; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2013 Sep; 23(7):1311-7. PubMed ID: 23839246
[TBL] [Abstract][Full Text] [Related]
11. Bone metastases in endometrial cancer: report on 19 patients and review of the medical literature.
Uccella S; Morris JM; Bakkum-Gamez JN; Keeney GL; Podratz KC; Mariani A
Gynecol Oncol; 2013 Sep; 130(3):474-82. PubMed ID: 23685013
[TBL] [Abstract][Full Text] [Related]
12. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
14. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in surgical stage III and IV carcinoma of the endometrium.
Kadar N; Homesley HD; Malfetano JH
Obstet Gynecol; 1994 Dec; 84(6):983-6. PubMed ID: 7970482
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
[TBL] [Abstract][Full Text] [Related]
20. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer.
Lin LL; Grigsby PW; Powell MA; Mutch DG
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):500-4. PubMed ID: 16168841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
